Cargando…
Thalidomide Prevents the Progression of Peritoneal Fibrosis in Mice
Thalidomide is clinically recognized as a therapeutic agent for multiple myeloma and has been known to exert anti-angiogenic actions. Recent studies have suggested the involvement of angiogenesis in the progression of peritoneal fibrosis. The present study investigated the effects of thalidomide on...
Autores principales: | Arai, Hideyuki, Furusu, Akira, Nishino, Tomoya, Obata, Yoko, Nakazawa, Yuka, Nakazawa, Masayuki, Hirose, Misaki, Abe, Katsushige, Koji, Takehiko, Kohno, Shigeru |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Japan Society of Histochemistry and Cytochemistry
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096082/ https://www.ncbi.nlm.nih.gov/pubmed/21614166 http://dx.doi.org/10.1267/ahc.10030 |
Ejemplares similares
-
Involvement of Leptin in the Progression of Experimentally Induced Peritoneal Fibrosis in Mice
por: Nakazawa, Masayuki, et al.
Publicado: (2013) -
The Transfer of the Hepatocyte Growth Factor Gene by Macrophages Ameliorates the Progression of Peritoneal Fibrosis in Mice
por: Obata, Yoko, et al.
Publicado: (2023) -
New Insights into Therapeutic Strategies for the Treatment of Peritoneal Fibrosis: Learning from Histochemical Analyses of Animal Models
por: Kitamura, Mineaki, et al.
Publicado: (2014) -
Renal outcomes of treatment with telmisartan in patients with stage
3–4 chronic kidney disease: A prospective, randomized, controlled trial
(JINNAGA)
por: Kitamura, Mineaki, et al.
Publicado: (2020) -
Evaluation of Candida peritonitis with underlying peritoneal fibrosis and efficacy of micafungin in murine models of intra-abdominal candidiasis
por: Ashizawa, Nobuyuki, et al.
Publicado: (2019)